Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 6,538,000 | 6,796,000 | 6,432,000 | 6,452,000 | 5,958,000 |
| Cost of Goods | 1,616,000 | 1,555,000 | 1,504,000 | 1,405,000 | 1,369,000 |
| Gross Profit | 4,922,000 | 5,241,000 | 4,928,000 | 5,047,000 | 4,589,000 |
| Operating Expenses | 2,503,000 | 2,883,000 | 2,567,000 | 2,660,000 | 2,311,000 |
| Operating Income | 2,419,000 | 2,358,000 | 2,361,000 | 2,387,000 | 2,278,000 |
| Interest Expense | 273,000 | 316,000 | 271,000 | 245,000 | 215,000 |
| Other Income | -60,000 | -44,000 | -76,000 | -46,000 | -287,000 |
| Pre-tax Income | 2,086,000 | 1,998,000 | 2,014,000 | 2,096,000 | 1,776,000 |
| Income Tax | 375,000 | 607,000 | 416,000 | 486,000 | 422,000 |
| Net Income Continuous | 1,711,000 | 1,391,000 | 1,598,000 | 1,610,000 | 1,354,000 |
| Net Income | $1,711,000 | $1,391,000 | $1,598,000 | $1,610,000 | $1,354,000 |
| EPS Basic Total Ops | 0.11 | 0.09 | 0.10 | 0.10 | 0.09 |
| EPS Basic Continuous Ops | 0.11 | 0.09 | 0.10 | 0.10 | 0.09 |
| EPS Diluted Total Ops | 0.11 | 0.09 | 0.10 | 0.10 | 0.09 |
| EPS Diluted Continuous Ops | 0.11 | 0.09 | 0.10 | 0.10 | 0.09 |
| EBITDA(a) | $2,733,000 | $2,642,000 | $2,589,000 | $2,630,000 | $2,259,000 |